Thiel Carsten 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 4, 2018
Insider Transaction Report
Form 4
Thiel Carsten
Director
Transactions
- Award
Nonstatutory stock option (right to buy)
2018-08-31+34,000→ 34,000 totalExercise: $21.05Exp: 2028-08-30→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]This option was granted on August 31, 2018. The shares underlying this option vest as to one-third (1/3) of the shares on August 31, 2019 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.